GTHCX
Price
$17.62
Change
-$0.11 (-0.62%)
Updated
Jan 17 closing price
Net Assets
1.24B
JFNIX
Price
$67.99
Change
-$0.36 (-0.53%)
Updated
Jan 17 closing price
Net Assets
4.78B
Ad is loading...

GTHCX vs JFNIX

Header iconGTHCX vs JFNIX Comparison
Open Charts GTHCX vs JFNIXBanner chart's image
Invesco Health Care C
Price$17.62
Change-$0.11 (-0.62%)
VolumeN/A
Net Assets1.24B
Janus Henderson Global Life Sciences I
Price$67.99
Change-$0.36 (-0.53%)
VolumeN/A
Net Assets4.78B
GTHCX vs JFNIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GTHCX vs. JFNIX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTHCX is a Buy and JFNIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.78B vs. GTHCX (1.24B). JFNIX pays higher dividends than GTHCX: JFNIX (0.15) vs GTHCX (0.00). GTHCX was incepted earlier than JFNIX: GTHCX (26 years) vs JFNIX (16 years). GTHCX is a more actively managed with annual turnover of: 59.00 vs. JFNIX (34.00). GTHCX has a lower initial minimum investment than JFNIX: GTHCX (1000) vs JFNIX (1000000). JFNIX annual gain was more profitable for investors over the last year : -3.13 vs. GTHCX (-5.62). JFNIX return over 5 years is better than : 12.85 vs. GTHCX (-36.32).
GTHCXJFNIXGTHCX / JFNIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years16 years-
Gain YTD2.981-0.044-6,759%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.24B4.78B26%
Annual Yield % from dividends0.000.15-
Returns for 1 year-5.62-3.13180%
Returns for 3 years-4.248.32-51%
Returns for 5 years-36.3212.85-283%
Returns for 10 years-48.1230.00-160%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NN12.990.20
+1.56%
NextNav
BIP31.220.30
+0.97%
Brookfield Infrastructure Partners LP
HTGC20.750.08
+0.39%
Hercules Capital
NKTR0.89N/A
+0.03%
Nektar Therapeutics
UXIN4.53-0.16
-3.41%
Uxin Limited